Amdocs Limited

Amdocs Limited

Ticker: DOX

Class Period Start: 12/13/2016

Class Period End: 03/10/2021

Registration Deadline: 06/08/2021

On March 31, 2021, before markets opened, Jehoshaphat Research published a report alleging that Amdocs Limited (“Amdocs” or the “Company”) overstated its profits, evidenced by steady parent profits despite declining subsidiary profits. The report also noted there was a concerning pattern of reputable auditors resigning, only to be replaced by “scandal-plagued or tiny shops.”  Furthermore, the report alleged that the Company “window-dressed” its balance sheets to keep its large borrowing a secret, and former employees and direct competitors corroborated the findings, including a former American Amdocs executive, who stated, “The US business was declining at a rate of [around] 7% annually . . . but then we would see the company [publish results that] say North America is stable.”

On this news, Amdocs’ stock price fell $9.19 per share, or 11.58%, to close at on March 30, 2021 to open at $70.15 on March 31, 2021.

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose to investors that: (1) the Company had overstated its profits, cash, and liquidity, while understating its debt; (2) the Company had concealed its large borrowing; (3) while the Company’s reported results showed that its North American business was stable, that business was actually deteriorating annually, in part because the Company was losing AT&T as a customer; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Purchases

Sales

Please Note

Neither the submission to nor the receipt of information by Lowey Dannenberg or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* Indicates a required field.

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.